Lack of correlation between arterial and venous β-adrenergic receptor sensitivity

Hypertension

Volumn 29, Issue 6, 1997, Pages 1273-1277

  Stein, C Michael ^a   Deegan, Robert ^a   Wood, Alastair J J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

arteries; isoproterenol; vasodilation; veins

Indexed keywords

BETA ADRENERGIC RECEPTOR; ISOPRENALINE;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; DATA ANALYSIS; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; VASCULAR RESISTANCE; VASODILATATION;

EID: 0030970478     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.6.1273     Document Type: Article

References (31)

1. Sumner DJ, Elliot HL, Vincent J, Reid JL. A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man. Br J Clin Pharmacol. 1987;23: 505-510.
2. Collier JG, Nachev C, Robinson BF. Effect of catecholamines and other vasoactive substances on superficial hand veins in man. Clin Sci. 1972;43:455-467.
3. Aellig WH. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol. 1981;11:237-243.
4. Whitney RJ. The measurement of volume changes in human limbs. J Physiol. 1953;121:1-27.
5. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 1995;25:918-923.
6. Roddie IC, Wallace WFM. Methods for the assessment of the effects of drugs on the arterial system in man. Br J Clin Pharmacol. 1979;7:317-323.
7. Alradi AO, Carruthers SG. Evaluation and application of the linear variable differential transformer technique for the assessment of human dorsal hand vein alpha-receptor activity. Clin Pharmacol Ther. 1985;38:495-502.
8. Aellig WH. Superficial hand and foot veins show no difference in sensitivity to constrictor agents. Clin Pharmacol Ther. 1990;48: 96-101.
9. Bodmer CW, Patrick AW, How TV, Williams G. Exaggerated sensitivity to norepinephrine-induced vasoconstriction in IDDM patients with microalbuminuria: possible etiology and diagnostic implications. Diabetes. 1992;41:209-214.
10. Aellig WH. Clinical pharmacology, physiology and pathophysiology of superficial veins, 1. Br J Clin Pharmacol. 1994;38:181-196.
11. Aellig WH. Clinical pharmacology, physiology and pathophysiology of superficial veins, 2. Br J Clin Pharmacol. 1994;38:289-305.
12. Feldman RD. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest. 1990;85:647-652.
13. Naslund T, Silbertstein DJ, Merrell WJ, Nadeau JH, Wood AJJ. Low sodium intake corrects abnormality in beta-receptor mediated arterial vasodilation in patients with hypertension: correlation with beta-receptor function in vitro. Clin Pharmacol Ther. 1990;48:87-95.
14. Stein CM, Nelson R, Brown M, He H, Deegan R, Wood M, Wood AJJ. Forearm beta-adrenergic receptor-mediated vasodilation is impaired without alteration of norepinephrine spillover in borderline hypertension. J Clin Invest. 1995;96:579-585.
15. Pan HYM, Hoffman BB, Pershe RA, Blaschke TF. Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther. 1986;239:802-807.
16. Van Brummelen P, Buhler FR, Kiowski W; Amman FW. Agerelated decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci. 1981;60: 571-577.
17. Lang CC, Stein CM; Brown RM, Deegan R, Nelson R, He HB, Wood M, Wood AJJ. Attenuation of isoproterenol-mediated vasodilation in blacks. N Engl J Med. 1995;333:155-160.
18. 2-adrenergic agonist-induced venodilation in Indians of Asian origin. Clin Pharmacol Ther. 1996; 59:569-576.
19. Stein M, Deegan R, He H, Wood AJJ. Beta adrenergic receptor mediated release of norepinephrine in the human forearm. Clin Pharmacol Ther. 1993;54:58-64.
20. 2 receptor agonist specifically desensitizes beta receptor-mediated venodilation. Clin Pharmacol Ther. 1993;54:187-193.
21. Stein CM, He H, Pincus T, Wood AJJ. Cyclosporine impairs vasodilation without increased sympathetic activity in humans. Hypertension. 1995;26:705-710.
22. Luscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, Yang Z, Turina M, Gradel E, Weber E, Buhler FR. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med. 1988;319:462-467.
23. Robinson BF, Collier JG. Vascular smooth muscle: correlations between basic properties and responses of human blood vessels. Br Med Bull. 1979;35:305-312.
24. Altura BM. Pharmacology of venules: some current concepts and clinical potential. J Cardiovasc Pharmacol. 1981;3:1413-1428.
25. J receptor blockade with oral practolol in man: a dose-related phenomenon. J Clin Invest. 1975;56:719-724.
26. 2 adrenoceptor-mediated relaxation of the isolated human saphenous vein. J Pharmacol Exp Ther. 1987;241:294-299.
27. 1 receptor-mediated human vascular smooth muscle relaxation. J Cardiovasc Pharmacol. 1992;19:447-452.
28. Stein CM, Nelson R, Deegan R, He H, Inagami T, Frazer M, Badr K, Wood M, Wood AJJ. Tachyphylaxis of human forearm vascular responses do not occur rapidly after exposure to isoproterenol. Hypertension. 1995;25:1294-1300.
29. Vincent J, Blaschke TF, Hoffman BB. Vascular reactivity to phenylephrine and angiotensin II: comparison of direct venous and systemic vascular responses. Clin Pharmacol Ther. 1992;51:68-75.
30. Zarnke KB, Feldman RD. Direct angiotensin converting enzyme inhibitor-mediated venodilation. Clin Pharmacol Ther. 1996;59:59-68.
31. Eichler HG, Blaschke TF, Hoffman BB. Decreased responsiveness of superficial hand veins to phenylephrine in black normotensive males. J Cardiovasc Pharmacol. 1990;16:177-181.